Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART) - Strowitzki, Thomas (BioMed Central, 2016)
Wissenschaftlicher Aufsatz. - Aus: Reproductive Biology and Endocrinology, 14 (2016), Nr. 1. pp. 1-12. ISSN 1477-7827